Characterization of a specific polyclonal antibody against 13- hydroperoxyoctadecadienoic acid-modified protein: Formation of lipid hydroperoxidemodified apoB-100 in oxidized LDL

Journal of Lipid Research

Volumn 38, Issue 7, 1997, Pages 1334-1346

  Kato, Yoji ^a   Makino, Yuko ^a   Osawa, Toshihiko ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Antibody; Lipid hydroperoxide; Oxidized LDL; Protein modification

Indexed keywords

13 HYDROPEROXYOCTADECADIENOIC ACID; 2,2' AZOBIS(2 AMIDINOPROPANE); ALDEHYDE; APOLIPOPROTEIN B100; BOVINE SERUM ALBUMIN; COPPER; LINOLEIC ACID; LINOLENIC ACID; LIPID; LIPID HYDROPEROXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS; APOLIPOPROTEINS B; HEMOCYANIN; IMMUNOBLOTTING; LINOLEIC ACIDS; LIPID PEROXIDES; LIPOPROTEINS, LDL; METALS; PEPTIDE FRAGMENTS; SERUM ALBUMIN, BOVINE;

EID: 0030860834     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Esterbauer, H., R. J. Schaur, and H. Zollner. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11: 81-128.
2. Haberland, M. E., D. Fong, and L. Cheng. 1988. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241: 215-218.
3. Ylä-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
4. Palinski, W., M. E. Rosenfeld, S. Ylä-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86: 1372-1376.
5. Rosenfeld, M. E., W. Palinski, S. Ylä-Herttuala, S. Butler, and J. L. Witztum. 1990. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arterosclerosis. 10: 336-349.
6. Jürgens, G., A. Ashy, and H. Esterbauer. 1990. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein [a] and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein. Biochem. J. 265: 605-608.
7. Palinski, W., S. Ylä-Herttuala, M. E. Rosenfeld, S. W. Butler, S. A. Socher, S. Parthasarathy, L. K. Curtiss, and J. L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10: 325-335.
8. Hammer, A., G. Kager, G. Dohr, H. Rabl, I. Ghassempur, and G. Jürgens. 1995. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoprotein. Arterioscler. Thromb. Vasc. Biol. 15: 704-713.
9. Shimasaki, H., N. Ueta, and O. S. Privett. 1982. Covalent binding of peroxidized linoleic acid to protein and amino acids as models for lipofuscin formation. Lipids. 17: 878-883.
10. Fruebis, J., S. Parthasarathy, and D. Steinberg. 1992. Evidence for a concerted reaction between lipid hydroperoxides and polypeptides. Proc. Natl. Acad. Sci. USA. 89: 10588-10592.
11. Hidalgo, F. J., and R. Zamora. 1995. In vitro production of long chain pyrrole fatty esters from carbonyl-amine reactions. J. Lipid Res. 36: 725-735.
12. Magil, A. B., J. J. Frohlich, S. M. Innis, and U. P. Steinbrecher. 1993. Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int. 43: 1243-1250.
13. Itabe, H., E. Takeshima, H. Iwasaki, J. Kimura, Y. Yoshida, T. Imanaka, and T. Takano. 1994. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphaticlylcholines and polypeptides. J. Biol. Chem. 269: 15274-15279.
14. Verhagen, J., A. A. Bouman, J. F. C. Vliegenthart, and J. Boldingh. 1977. Conversion of 9-D- and 13-L-hydroperoxylinolenic acids by soybean lipoxygenase-1 under anaerobic conditions. Biochim. Riophys. Acta. 486: 114-120.
15. Yagi, K., K. Kiuchi, Y. Saito, A. Miike, N. Kayahara, T. Tatano, and N. Ohishi. 1986. Use of a new methylene blue derivative for the determination of lipid peroxides in foods. Biochem. Int. 12: 367-371.
16. Steinberg, U. P., M. Lougheed, W.-C. Kwan, and M. Dirks. 1989. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264: 15216-15223.
17. Steinbrecher, U. P. 1987. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262: 3603-3608.
18. Nakayama, H., S. Taneda, S. Kuwajima, S. Aoki, Y. Kuroda, K. Misawa, and S. Nakagawa. 1989. Production and characterization antibodies to advanced glycation products on proteins. Biochem. Biophys. Res. Commun. 162: 740-745.
19. Horiuchi, S., N. Araki, and Y. Morino. 1991. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. J. Biol. Chem. 266: 7329-7332.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
21. Ellman, G. L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77.
22. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271: 9982-9986.
23. Kato, Y., K. Tokunaga, and T. Osawa. 1996. Immunochemical detection of carboxymethylated apoB-100 in copper-oxidized LDL. Biochem. Biophys. Res. Commun. 226: 923-927.
24. ε-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 34: 10872-10878.
25. Soriani, M., D. Pietraforte, and M. Minetti. 1994. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch. Biochem. Biophys. 312: 180-188.
26. Isles, T. E., and P. C. Jocelyn. 1963. The reaction of protein thiol groups with some disulphides. Biochem. J. 88: 84-88.
27. Fowler, S., H. Shio, and N. J. Haley. 1979. Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. Lab. Invest. 41: 372-378.
28. Schaffner, T., K. Taylor, E. J. Bartucci, K. Fischer-Dzoga, J. H. Beeson, S. Glagov, and R. W. Wissler. 1980. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 100: 57-80.
29. Gerrity, R. G. 1981. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181-190.
30. Tsukada, T., R. Ross, and A. M. Gown. 1985. Smooth muscle cell- and macrophage-specific monoclonal antibodies in the immunocytochemical analysis of human and rabbit atherosclerotic lesions. Arteriosclerosis. 5: 497a-498a.
31. Berliner, J. A., and J. W. Heinecke. 1996. The role of oxidized lipoprotein in atherogcnesis. Free Radical Biol. Med. 20: 707-727.
32. Steinbrecher, U. P., H. Zhang, and M. Lougheed. 1990. Role of oxidatively modified LDL in atherosclerosis. Free Radical Biol. Med. 9: 155-168.
33. Kühn, H., J. Belkner, H. Suzuki, and S. Yamamoto. 1994. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J. Lipid Res. 35: 1749-1759.
34. Ezaki, M., J. L. Witztum, and D. Steinberg. 1995. Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase. J. Lipid Res. 36: 1996-2004.
35. Benz, D. J., M. Mol, M. Ezaki, N. Mori-Ito, I. Zelán, A. Miyanohara, T. Friedmann, S. Parthasarathy, D. Steinberg, and J. L. Witztum. 1995. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblasts expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270: 5191-5197.
36. Belkner, J., R. Wiesner, J. Rathman, J. Barnett, E. Sigal, and H. Kühn. 1993. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur. J. Biochem. 213: 251-261.
37. Ylä-Herttuala, S., M. E. Rosenfeld, S. Parthasarathy, E. Sigal, T. Särkioja, J. L. Witztum, and D. Steinberg. 1991. Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87: 1146-1152.
38. Ylä-Herttuala, S., M. E. Rosenfeld, S. Parthasarathy, C. K. Glass, E. Sigal, J. L. Witztum, and D. Steinberg. 1990. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87: 6959-6963.
39. Chio, K. S., and A. L. Tappel. 1969. Inactivation of ribonuclease and other enzymes by peroxidizing lipids and by malonaldehyde. Biochemistry. 8: 2827-2832.
40. Chio, K. S., and A. L. Tappel. 1969. Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry. 8: 2821-2827.
41. Kikugawa, K., Y. Machida, M. Kida, and T. Kurechi. 1981. Studies on peroxidized lipids. III. Fluorescent pigments derived from the reaction of malonaldehyde and amino acids. Chem. Pharm. Bull. 29: 3003-3011.
42. Jürgens, G., J. Lang, and H. Esterbauer. 1986. Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta. 875: 103-114.
43. Uchida, K., and E. R. Stadtman. 1992. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA. 89: 4544-4548.
44. Holvoet, P., G. Perez, Z. Zhao, E. Brouwers, H. Bernar, and D. Collen. 1995. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic diseases. J. Clin. Invest. 95: 2611-2619.
45. Montine, T. J., V. Amarnath, M. E. Martin, W. J. Strittmatter, and D. G. Graham. 1996. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148: 89-93.
46. Uchida, K., K. Itakura, S. Kawakishi, H. Hiai, S. Toyokuni, and E. R. Stadtman. 1995. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 324: 241-248.
47. Gan, Q.-F., G. L. Witkop, D. L. Sloane, K. M. Straub, and E. Sigal. 1995. Identification of a specific methionine in mammalian 15-lipoxygenase which is oxygenated by the enzyme product 13-HPODE: dissociation of sulfoxide formation from self-inactivation. Biochemistry. 34: 7069-7079.
48. Lepley, R. A., and F. A. Fitzpatrick. 1994. Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes. J. Biol. Chem. 269: 2627-2631.
49. Härtel, B., P. Ludwig, T. Schewe, and S. M. Rapoport. 1982. Self-inactivation by 13-hydroperoxylinoleic acid and lipohydroperoxidase activity of the reticulocyte lipoxygenase. Eur. J. Biochem. 126: 353-357.
50. Kishimoto, K., M. Nakamura, H. Suzuki, T. Yoshimoto, S. Yamamoto, T. Takao, Y. Shimonishi, and T. Tanabe. 1996. Suicide inactivation of porcine leukocyte 12-lipoxygenase associated with its incorporation and 15-hydroperoxy-5, 8, 11, 13-eicosatetraenoic acid derivative. Biochim. Biophys. Acta. 1300: 56-62.
51. 4. Mass spectrometric and kinetic characterization. J. Biol. Chem. 267: 22733-22739.